Subscribe for the Newsletter

Mobile Navigation

Bringing Artificial Intelligence to Biopharma

TeselaGen Biotechnology

TeselaGen Biotechnology

Apr 1, 2022PAO-04-22-R250-07

At another stop on Pharma's Almanac's the Road to 50 States campaign, Mike Fero, Founder and CEO of TeselaGen Biotechnology, talks to Nigel about the similarities between physics and biology and the informatic platforms TeselaGen offers to biotech companies.

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.